Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Research

• Publication date

  2006-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-06-1271PMID 17018624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of beta-arrestin 1 in the metastatic progression of colorectal cancer.

  2006cited by this paper
• Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis.

  2006cited by this paper
• Role of β-arrestin 1 in the metastatic progression of colorectal cancer

  2006cited by this paper
• Targeting Cyclooxygenase-2 in Recurrent Non–Small Cell Lung Cancer: A Phase II Trial of Celecoxib and Docetaxel

  2005cited by this paper
• Activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) increases the expression of prostaglandin E2 receptor subtype EP4. The roles of phosphatidylinositol 3-kinase and CCAAT/enhancer-binding protein beta.

  2005cited by this paper
• Differential Regulation of Phosphorylation of the cAMP Response Element-Binding Protein after Activation of EP2 and EP4 Prostanoid Receptors by Prostaglandin E2

  2005cited by this paper
• Identification of Necrosis-Associated Genes in Glioblastoma by cDNA Microarray Analysis

  2004cited by this paper
• Chemoprevention of Prostate Cancer: Current Status and Future Directions

  2004cited by this paper
• Nonmyeloablative stem cell transplantation for lymphoma.

  2004cited by this paper
• Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc[Δ716] knockout mice

  2004cited by this paper
• Future options with capecitabine (Xeloda) in (neo)adjuvant treatment of breast cancer.

  2004cited by this paper
• The role of COX-2 inhibition in breast cancer treatment and prevention.

  2004cited by this paper
• PGE2‐mediated upregulation of iNOS in murine breast cancer cells through the activation of EP4 receptors

  2004cited by this paper
• Cyclooxygenase as a Target in Lung Cancer

  2004cited by this paper
• Coxibs and cardiovascular disease.

  2004cited by this paper
• Endothelin-1-induced Prostaglandin E2-EP2, EP4 Signaling Regulates Vascular Endothelial Growth Factor Production and Ovarian Carcinoma Cell Invasion*

  2004cited by this paper
• Pulmonary Prostacyclin Synthase Overexpression Chemoprevents Tobacco Smoke Lung Carcinogenesis in Mice

  2004cited by this paper
• COX-2-Derived Prostacyclin Confers Atheroprotection on Female Mice

  2004cited by this paper
• COX-2 inhibition and colorectal cancer.

  2004cited by this paper
• COX-2 inhibition and lung cancer.

  2004cited by this paper
• A ride on the ferrous wheel

  2004cited by this paper
• Colon Carcinoma Cell Growth Is Associated with Prostaglandin E2/EP4 Receptor-evoked ERK Activation*

  2004cited by this paper
• Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer?

  2004cited by this paper
• Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice

  2003cited by this paper
• Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.

  2003cited by this paper
• Prostaglandin E2 Induced Functional Expression of Early Growth Response Factor-1 by EP4, but Not EP2, Prostanoid Receptors via the Phosphatidylinositol 3-Kinase and Extracellular Signal-regulated Kinases*

  2003cited by this paper
• Prostaglandin E2–EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells

  2003cited by this paper
• Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor.

  2003cited by this paper
• Role of prostaglandin E produced by osteoblasts in osteolysis due to bone metastasis.

  2003cited by this paper
• Prostaglandin E2 Regulates Cell Migration via the Intracellular Activation of the Epidermal Growth Factor Receptor*

  2003cited by this paper
• EP2 and EP4 prostanoid receptor signaling.

  2003cited by this paper
• Expressions of cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder: crucial role of arachidonate metabolism in tumor growth and progression.

  2002cited by this paper
• The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut.

  2002cited by this paper
• Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.

  2002cited by this paper
• Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer.

  2002cited by this paper
• Role of Prostacyclin in the Cardiovascular Response to Thromboxane A2

  2002cited by this paper
• Prostaglandin E2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy

  2002cited by this paper
• COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease.

  2002cited by this paper
• Function of prostanoid receptors: studies on knockout mice.

  2002cited by this paper
• Autocrine/Paracrine Prostaglandin E2 Production by Non-small Cell Lung Cancer Cells Regulates Matrix Metalloproteinase-2 and CD44 in Cyclooxygenase-2-dependent Invasion*

  2002cited by this paper
• Expression of COX-2 and PGE synthase and synthesis of PGE2 in endometrial adenocarcinoma: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors

  2001cited by this paper
• Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors.

  2001cited by this paper
• Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells*

  2001cited by this paper
• Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice

  2001cited by this paper
• Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.

  1999cited by this paper
• Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.

  1998cited by this paper
• Cyclooxygenase regulates angiogenesis induced by colon cancer cells.

  1998cited by this paper
• Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production.

  1998cited by this paper
• Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.

  1998cited by this paper
• Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice.

  1998cited by this paper
• Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.

  1997cited by this paper
• G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2.

  1996cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer.

  1995cited by this paper
• Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.

  1994cited by this paper
• Activation of PPAR β / δ increases the expression of prostaglandin E 2 receptor subtype EP4: the role of PI3-K and C/EBP β

  year unknowncited by this paper

• Design and synthesis of Prostanoid EP4 receptor antagonists for treatment of inflammatory pain.

  2025cites this paper
• The Role of Prostaglandins as Major Inflammatory Mediators in Colorectal Cancer

  2025cites this paper
• Prostaglandin E2-EP2/EP4 signaling induces immunosuppression in human cancer by impairing bioenergetics and ribosome biogenesis in immune cells

  2024cites this paper
• Piperine Reduces Neoplastic Progression in Cervical Cancer Cells by Downregulating the Cyclooxygenase 2 Pathway

  2023cites this paper
• TFF3 promotes clonogenic survival of colorectal cancer cells through upregulation of EP4 via activation of STAT3

  2023cites this paper
• Synthesis, anti-cancer activity and molecular docking studies of new nicotinamide containing EP4 antagonists

  2022cites this paper
• Blocking EP4 downregulates tumor metabolism and synergizes with anti-PD-1 therapy to activate natural killer cells in a lung adenocarcinoma model.

  2022cites this paper
• A Novel Small Molecular Prostaglandin Receptor EP4 Antagonist, L001, Suppresses Pancreatic Cancer Metastasis

  2022cites this paper
• Fatty acid desaturase 1 (FADS1) is a cancer marker for patient survival and a potential novel target for precision cancer treatment

  2022cites this paper
• Changing prostaglandin E2 (PGE2) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE2 receptor EP2 and EP4

  2021cites this paper
• Therapeutic Potential

  2021cites this paper
• Eicosanoid regulation of debris-stimulated metastasis

  2021cites this paper
• Eicosanoids in Cancer: Prostaglandin E2 Receptor 4 in Cancer Therapeutics and Immunotherapy

  2020cites this paper
• Prostaglandin E2 receptor EP4 regulates cell migration through Orai1

  2019cites this paper
• Small molecules as drugs to upregulate metastasis suppressors in cancer cells.

  2018cites this paper
• Application of a dye-based mitochondrion-thermometry to determine the receptor downstream of prostaglandin E2 involved in the regulation of hepatocyte metabolism

  2018cites this paper
• The implications of signaling lipids in cancer metastasis

  2018cites this paper
• GPCR Modulation in Breast Cancer

  2018cites this paper
• Role of Cyclooxygenase-2 on Intermittent Hypoxia-Induced Lung Tumor Malignancy in a Mouse Model of Sleep Apnea

  2017cites this paper
• Structural features of subtype-selective EP receptor modulators.

  2017cites this paper
• Discovery of AAT-008, a novel, potent, and selective prostaglandin EP4 receptor antagonist.

  2017cites this paper
• Quantitative and systems pharmacology 2. In silico polypharmacology of G protein‐coupled receptor ligands via network‐based approaches

  2017cites this paper
• Eicosanoid receptors: Targets for the treatment of disrupted intestinal epithelial homeostasis

  2017cites this paper
• Cyclooxygenase 2: protein-protein interactions and posttranslational modifications.

  2017cites this paper
• Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer

  2016cites this paper
• Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer

  2016cites this paper
• Post-transcriptional Mechanisms in Endocrine Regulation

  2016cites this paper
• Prostaglandin E Receptor EP4 expression, survival and pattern of recurrence in locally advanced NSCLC.

  2016cites this paper
• Post-transcriptional Regulation of Prostaglandin Biosynthesis

  2016cites this paper
• PROGRAMA DE PÓS-GRADUAÇÃO EM GENÉTICA

  2015cites this paper
• Inflammation and Lung Cancer: Eicosanoids

  2015cites this paper
• Cyclooxygenase 2 inhibition in patients with non–small cell lung cancer: Is this still a valid target for therapy?

  2015cites this paper
• Direct Melanoma Cell Contact Induces Stromal Cell Autocrine Prostaglandin E2-EP4 Receptor Signaling That Drives Tumor Growth, Angiogenesis, and Metastasis*

  2015cites this paper
• Prostaglandin E receptor 4 (EP4) promotes colonic tumorigenesis

  2015cites this paper
• Inflammation and Lung Cancer

  2015cites this paper
• Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease.

  2015cites this paper
• Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?

  2015influential citation
• COX-2 signaling and cancer: new players in old arena.

  2014cites this paper
• The PGE2-EP Receptor Axis in Colorectal Cancer and Angiogenesis

  2014cites this paper
• Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties

  2014cites this paper
• An EP4 Antagonist ONO-AE3-208 Suppresses Cell Invasion, Migration, and Metastasis of Prostate Cancer

  2014cites this paper
• Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions

  2014cites this paper
• Significance of Divergent Expression of Prostaglandin EP4 and EP3 Receptors in Human Prostate Cancer

  2013cites this paper
• Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties

  2013cites this paper
• Chapter The Role of Cyclooxygenases and Lipoxygenases in the Regulation of Tumor Angiogenesis

  2013cites this paper
• The Prostanoid EP4 Receptor and Its Signaling Pathway

  2013cites this paper
• THE CONTRIBUTION OF INFLAMMATORY PATHWAY SIGNALING AND MICRORNA CHANGES TO COLON CANCER PROGRESSION

  2013cites this paper
• Receptorsthrough E-Prostanoid 2 Prostaglandin E2 Inhibits Eosinophil

  2013cites this paper
• E-type prostanoid receptor 4 (EP4) in disease and therapy

  2013cites this paper
• Multilevel pharmacological manipulation of adenosine-prostaglandin E₂/cAMP nexus in the tumor microenvironment: a 'two hit' therapeutic opportunity.

  2013cites this paper
• A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis

  2013cites this paper
• Role of prostanoid receptor EP1 in the progression of non-small cell lung cancer (NSCLC)

  2013cites this paper
• Prostaglandins in Cancer Cell Adhesion, Migration, and Invasion

  2012cites this paper
• MicroRNA-101 (miR-101) post-transcriptionally regulates the expression of EP4 receptor in colon cancers

  2012cites this paper
• Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model

  2012cites this paper
• Studier i adenokarsinomceller fra bukspyttkjertel: stimulering av cellemigrasjon og involverte signalveier

  2012cites this paper
• Involvement of β-arrestins in cancer progression

  2012cites this paper
• Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2

  2012cites this paper
• Central Nervous System and Innate Immune Mechanisms for Inflammation- and Cancer-induced Anorexia

  2012cites this paper
• ROLE OF PROSTAGLANDIN E2 IN THE REGULATION OF PANCREATIC STELLATE CELLS HYPER ACTIVITY ASSOCIATED WITH PANCREATIC CANCER

  2011cites this paper
• MicroRNA and AU-rich element regulation of prostaglandin synthesis

  2011cites this paper
• TITLE: Molecular Profiles for Lung Cancer Pathogenesis and Detection in US Veterans

  2011cites this paper
• Prostaglandin E2 EP receptors as therapeutic targets in breast cancer

  2011cites this paper
• Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention

  2011cites this paper
• Regulation of inflammation in cancer by eicosanoids.

  2011cites this paper
• International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress

  2011cites this paper
• Synthesis, pharmacophore modeling and in vitro activity of 10,11-dihydrodibenzo[b,f]oxepine-4-carboxamide derivatives as novel and potent antagonists of the prostaglandin EP4 receptor.

  2011cites this paper
• Cardiovascular Risk Markers and Mechanisms in Targeting the COX Pathway for Colorectal Cancer Prevention

  2011cites this paper
• Models for Evaluation of Targeted Therapies of Invasive and Metastatic Disease

  2011cites this paper
• Systematische Modifizierung von Arzneimitteln auf Basis nachwachsender Rohstoffe als ein Konzept für eine nachhaltige Chemie

  2011cites this paper
• Evolving Concepts in Lung Carcinogenesis

  2011cites this paper
• Molecular Profiles for Lung Cancer Pathogenesis and Detection in U.S. Veterans

  2011cites this paper
• Cyclooxygenases and lipoxygenases in cancer

  2011cites this paper
• Evolving concepts in lung carcinogenesis.

  2011cites this paper
• Clinical significance and predictive value of prostaglandin E2 receptors (EPR) 1 - 4 in patients with renal cell carcinoma.

  2011cites this paper
• Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP4 receptor.

  2011cites this paper
• Prostaglandin E₂ inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors.

  2011cites this paper
• Eicosanoids and cancer

  2010cites this paper
• 2 Murine L 1210 and P 388 Leukemias

  2010cites this paper
• Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model.

  2010cites this paper
• The discovery of 4-{1-[({2,5-dimethyl-4-[4-(trifluoromethyl)benzyl]-3-thienyl}carbonyl)amino]cyclopropyl}benzoic acid (MK-2894), a potent and selective prostaglandin E2 subtype 4 receptor antagonist.

  2010cites this paper
• Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4

  2010cites this paper
• Hepatic transcriptomic and metabolomic responses in the Stickleback (Gasterosteus aculeatus) exposed to ethinyl-estradiol.

  2010cites this paper
• Prostaglandin E2 Promotes Lung Cancer Cell Migration via EP4-βArrestin1-c-Src Signalsome

  2010cites this paper
• Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells.

  2010cites this paper
• Pharmacological strategies and micrometastasis: what is known? What must be done?

  2010cites this paper
• Prostaglandin E Receptor EP1 Suppresses Breast Cancer Metastasis and Is Linked to Survival Differences and Cancer Disparities

  2010cites this paper
• Scalable synthesis of a prostaglandin EP4 receptor antagonist.

  2010cites this paper
• staglandin E Receptor EP1 Suppresses Breast Cancer astasis and Is Linked to Survival Differences

  2010cites this paper
• 677 IDENTIFICATION OF EP4 AS A POTENTIAL TARGET FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER USING A NOVEL XENOGRAFT MODEL

  2010cites this paper
• Selektive ep4-rezeptoragonistensubstanz zur krebsbehandlung

  2010cites this paper
• Immunologic Mechanisms in Lung Carcinogenesis and Metastasis

  2009cites this paper
• Mouse models of colon cancer.

  2009cites this paper
• Regulation of EP receptors in non-small cell lung cancer by epigenetic modifications.

  2009cites this paper
• Remote electronic control in the regioselective reduction of succinimides: a practical, scalable synthesis of Ep4 antagonist MF-310.

  2009cites this paper
• G protein-coupled receptors stimulation and the control of cell migration.

  2009cites this paper
• Targeting the eicosanoid pathway in non-small-cell lung cancer

  2009cites this paper
• Transgenic expression of cyclooxygenase-2 in mouse intestine epithelium is insufficient to initiate tumorigenesis but promotes tumor progression.

  2009cites this paper
• Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function

  2009cites this paper
• The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment.

  2009cites this paper